2020
DOI: 10.1016/j.jinf.2020.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…This, in addition to the GGT elevation, has been described in the prior SARS outbreak [121], but is not typical of other viral hepatitis entities [122], like hepatitis B or C. It is more commonly seen in ischemic or congestive hepatopathy [123]. Therefore, direct viral injury may not be the only pathophysiology of liver injury in COVID-19 [124,125].…”
Section: Discussionmentioning
confidence: 95%
“…This, in addition to the GGT elevation, has been described in the prior SARS outbreak [121], but is not typical of other viral hepatitis entities [122], like hepatitis B or C. It is more commonly seen in ischemic or congestive hepatopathy [123]. Therefore, direct viral injury may not be the only pathophysiology of liver injury in COVID-19 [124,125].…”
Section: Discussionmentioning
confidence: 95%
“…Alanine aminotransferase (ALT) is mainly found in hepatocytes, while aspartate aminotransferase (AST) mainly exists in the myocardium, followed by liver, kidney, and other tissues (Smith et al, 2020). Generally, the content of serum AST is low, but AST will be released into the blood when cells are injured, thus, AST is often used as a serum enzyme index for the diagnosis of liver injury (Vonbank et al, 2015;Li, 2020). Determination of serum ALT, AST, TG, and other indexes is very important for evaluation of nonalcoholic fatty liver.…”
Section: Discussionmentioning
confidence: 99%